The FIDELIO-DKD trial provided pivotal evidence supporting the efficacy of finerenone in patients with type 2 diabetes and CKD (177)
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 18 Relative Effectiveness and Safety of the GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics: A Prospective Observational Cohort Study in Poland Authors Hoffmann K, Michalak M , Paczkowska A Received 1 April 2025 Accepted for publication 1 July 2025 Published 7 August 2025 Volume 2025:18 Pages 27232738 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Halis Akturk Karolina Hoffmann, 1 Micha Michalak, 2 Anna Paczkowska 3 1 Department and Clinic of Internal Diseases and Metabolic Disorders, Poznan University of Medical Sciences, Pozna, Poland
Eating smaller meals throughout the day rather than large portions, avoiding high-fat foods especially early in treatment, emphasizing protein and vegetables over processed carbohydrates, and staying well-hydrated all help minimize discomfort
Denying Ozempic does not rule out Wegovy, which contains the same active molecule at a higher maintenance dose
We will discuss your options and make sure that you are fully informed before beginning treatment
Cell Cycle Assay When the confluence reached ~7080%, cells (1 10 6 /ml) were collected and fixed in ethanol (70%) at a temperature of 20C for more than 18 h
